Circulating Hepcidin Levels Are an Independent Predictor of Survival in Microsatellite Stable Metastatic Colorectal Cancer Patient Candidates for Standard First-Line Treatment
Our data show that baseline serum levels of hepcidin are an independent risk factor for OS in MSS mCRC patients undergoing standard first-line treatment. Further prospective and extensive studies are needed to confirm and validate our findings.
Authors
- Vincenzo Formica (ORCID: https://orcid.org/0000-0002-5380-3144)
- Roberto Mancone (ORCID: https://orcid.org/0000-0003-3437-7079)
- Antonio Di Grazia
- Maria Vittoria Bonomo
- Rachele Frascatani
- Giovanni Monteleone (ORCID: https://orcid.org/0000-0003-1339-9076)
Institutions
- University of Rome Tor Vergata (IT)
- Policlinico Tor Vergata (IT)
Publication Details
- Journal
- Cancers
- Published
- 2024-11-27
- DOI
- https://doi.org/10.3390/cancers16233977
- Citations
- 1
- Primary Topic
- Iron Metabolism and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.45
Funders
- Ministero della Salute